GLP-1 drugs for weight loss, like Saxenda and Wegovy , are FDA-approved for people with obesity (defined as a body mass index , or BMI, of 30 or higher ) or with a BMI of 27 or higher and a weight-related health condition, such as high cholesterol, type 2 diabetes, or high blood pressure
Learn why in the Cautions and Concerns section of our Protein Supplements Review
doi: 10.1016/S0165-1838(00)00110-7
An interesting one is kisspentin, so named because the gene that codes for it was discovered in Hershey, PA, the home of Hersheys Kisses. The researchers who conducted two clinical trials, one in men and one in women with hypoactive sexual desire disorder concluded that the administration of kisspentin has potential as a pharmacological treatment for low sexual desire. The catch is that the kisspentin was administered intravenously for 75 minutes and the results were based on brain scans that that monitored the response to erotic videos
It was just kind of one of those where, you know, let's try it and see what happens
3094 In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation